The Daily Buyout

Thursday, October 15, 2026

The Daily Buyout

35 deals · $22.5B announced

The Penske family and Mitsui are taking Penske Automotive private in a $16.3 billion deal, today's biggest move. Mubadala Capital closed its $6.2 billion Clear Channel Outdoor buyout, EQT is buying US real estate manager Stockbridge, and Aurora Cannabis is still fighting Curaleaf. Below that sits a deep bench of add-ons, roll-ups and tuck-ins.

Top deal of the day

Penske and Mitsui take Penske Automotive private at $212 a share

$16.3BTake-privateTransportation & Logistics

Penske Automotive Group agreed to be taken private by an entity owned by Penske Corporation and Mitsui & Co., which will pay public holders $212.00 per share in cash. The deal values the auto and commercial truck retailer at an enterprise value of about $16.3 billion. The price is an 8.84% premium to the October 14 close. Penske will own about 64% after closing and Mitsui about 36%.

Why it matters: It is one of the year's larger take-privates, and controlling holders are buying out the public float of a major global auto retailer.

Read at PR NewswireFree

Get this in your inbox every weekday

The day's biggest deals in five minutes. Free, with no paywalled links.

Free · Unsubscribe anytime

2
$6.2BTake-privateMedia & TelecomCompleted

Mubadala Capital closes $6.2B buyout of Clear Channel Outdoor

Mubadala Capital completed its acquisition of Clear Channel Outdoor Holdings in a deal valued at about $6.2 billion, after regulatory and shareholder approvals. Former TelevisaUnivision chief Wade Davis takes over as CEO and executive chairman, succeeding Scott Wells. Clear Channel's stock will be delisted from the NYSE.

Read at PR NewswireFree
4
UndisclosedHostile / unsolicited bidHealthcare & Life Sciences

Aurora Cannabis urges holders to reject Curaleaf's revised hostile bid

Aurora Cannabis's board unanimously reaffirmed that shareholders should reject Curaleaf's revised hostile offer, filed October 6. The board says the bid still significantly undervalues the debt-free company. A special committee is evaluating strategic alternatives, and Curaleaf's offer stays open until December 4, 2026.

Read at PR NewswireFree
5
~$225MreportedDivestiture / carve-outHealthcare & Life Sciences

Labcorp buys select BioReference Health assets from OPKO

Labcorp agreed to acquire select assets of BioReference Health from parent OPKO Health. The package covers clinical, women's health, urology and corrections testing businesses, more than 80 patient service centers, and the FDA-approved 4Kscore prostate cancer test. Terms were not disclosed.

Read at PR NewswireFree

Other deals this day29 more

Get tomorrow's edition in your inbox

Free · Unsubscribe anytime